Quantcast

Latest Artemisinin Stories

2014-09-30 04:22:22

2014 marks the first time The Economist's innovation initiative has come to Asia in its 13-year history HONG KONG, Sept. 30, 2014 /PRNewswire/ -- Winners of The Economist's prestigious Innovation awards 2014 will speak at The Economist Events' Innovation Summit scheduled to take place at the JW Marriott Hong Kong on Friday, October 10(th) 2014. At the summit, the award winners will share their experiences and the lessons those hold for others. The awards, which recognises outstanding people...

2014-08-12 08:29:21

First shipment marks a critical step in improving access to treatment worldwide PARIS and SOUTH SAN FRANCISCO, Calif., Aug. 12, 2014 /PRNewswire/ -- Sanofi (Euronext: SAN and NYSE: SNY) and PATH today announced the delivery of the first large-scale batches of antimalarial treatments manufactured with a new semisynthetic artemisinin derivative to malaria-endemic countries in Africa. The shipment signals a new era of lifesaving drugs made with safe, high-quality, and affordable...

2014-08-07 15:34:58

PLOS Preventative treatment with a monthly dose of a newer antimalarial drug can reduce the risk of malarial infection among young children, according to a study published in this week's PLOS Medicine. The study, conducted by Victor Bigira and colleagues at San Francisco General Hospital and the Makerere University College of Health Sciences in Kampala, Uganda, finds that treating young children with dihydroartemisinin-piperaquine (DP) decreased their risk of contracting malaria....

2014-08-01 12:26:55

Malaria No More, APLMA and the ADB join forces to mobilize resources and rally regional leadership in endemic Asia SINGAPORE, August 1st, 2014 /PRNewswire-USNewswire/ -- In an effort to fight malaria and the resistance to its front-line treatment in Asia, Malaria No More (MNM) has entered into a new partnership with the Asia-Pacific Leaders Malaria Alliance (APLMA) and the Asian Development Bank (ADB). An event to address current challenges in the region and bring new private sector...

2014-07-31 17:36:22

Wellcome Trust Drug-resistant malaria parasites have spread to critical border regions of Southeast Asia, seriously threatening global malaria control and elimination programs, according to a study published in the New England Journal of Medicine. The study confirms that resistance to the world's most effective antimalarial drug, artemisinin, is now widespread in Southeast Asia. This is not the first, or even the second time the malaria parasite has developed resistance to front line...

2014-01-22 11:47:15

‘Dihydroartemisinin-piperaquine is more effective than artemether-lumefantrine, and has fewer side effects than artesunate-mefloquine’ concludes a systematic review published by the Cochrane Infectious Disease Group, hosted by LSTM. Dihydroartemisinin-piperaquine is one of five artemisinin-based combination therapies currently recommended by the World Health Organization (WHO), and this review finds that it is also one of the most studied. The team of authors from South Africa, Kenya,...

2013-12-11 23:03:56

Despite gains, recent financial shortfalls and delays in the delivery of commodities have slowed progress, demonstrating the fragility of past success, according to findings of the World Health Organization’s World Malaria Report 2013. New York, NY (PRWEB) December 11, 2013 The World Health Organization’s World Malaria Report 2013, released today, notes continued progress to significantly reduce malaria cases and deaths. But the report also documents that financial shortfalls in 2011...

2013-12-04 10:38:28

An analysis of patients from across the malaria endemic world suggests that a key antimalarial treatment could be improved by better dosing in young children Antimalarial drug resistance has hampered malaria control programs for almost 60 years. A key factor in combatting this threat is to ensure that all antimalarial drugs are deployed in a way that ensures that the maximum number of patients are completely cured. A study published this week in PLOS Medicine explores this issue by...

2013-10-30 10:48:05

The first dynamic regulatory system that prevents the build-up of toxic metabolites in engineered microbes has been reported by a team of researchers with the U.S. Department of Energy (DOE)’s Joint BioEnergy Institute (JBEI). The JBEI researchers used their system to double the production in Escherichia coli (E. coli) of amorphadiene, a precursor to the premier antimalarial drug artemisinin. Using genome-wide transcriptional analysis, the JBEI researchers identified native regions of...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.